Integrated Gulf Biosystems | The Life Sciences Partner You Can Trust

Immuno-Oncology Assays

Overview:

IGB offers an unmatched offering of NGS testing solutions and capabilities to better understand tumor -immune interactions and examine the immune-repertoire at an unprecedented level. Learn how NGS can be used to study tumor mutation load, clonal expansion, and TCR convergence, enabling biomarker discovery and predictive outcomes for immunotherapies in the future.

For human research studies:

TCR beta assays for deeper insights in clonality and convergence
BCR IgH assays to quantify somatic hypermutations and study isotypes
Immune response assay to monitor the tumor microenvironment
Tumor mutation load assay for accurate quantification of TMB

For mouse studies:

Sequencing assays to interrogate CDR3 for TCR beta and for BCR IgH, enabling deeper insights in repertoire analysis

Assay Options:

Our Resources

Oncomine Solutions

Let’s Connect with Expert

Full Name *

Email Address *

Phone*

Address*

Country / Region*

Remarks

From time to time, we may contact you about our products, services, and other content that may be of interest to you. If you would like to receive such communications, please provide your consent below:

I agree to receive communications from Integrated Gulf Biosystems *
You can unsubscribe at any time. For more information on how we manage your data, please review our Privacy Policy .
By submitting this form, you consent to Integrated Gulf Biosystems storing and processing your personal data to provide the requested content.

Workflow

Instruments

Consumables

Services

Immuno-Oncology Assays

Our Resources

Download Catalog